Tethering pH-Induced structural modifications of ovomucin to stabilize W1/O/W2 double emulsions for enhanced protection of Companilactobacillus crustorum MN047
Ovomucin (OVM) exhibits pH-responsive conformational changes, aggregating under acidic conditions and extending under alkaline conditions, making it a promising stabilizer for double emulsions (DEs) designed to protect probiotics in the gastrointestinal environment. This study presents an OVM-based...
Gespeichert in:
Veröffentlicht in: | Food hydrocolloids 2025-06, Vol.163, p.111060, Article 111060 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Ovomucin (OVM) exhibits pH-responsive conformational changes, aggregating under acidic conditions and extending under alkaline conditions, making it a promising stabilizer for double emulsions (DEs) designed to protect probiotics in the gastrointestinal environment. This study presents an OVM-based DE system for the efficient encapsulation and delivery of Companilactobacillus crustorum MN047. The primary W1/O emulsion was formed by homogenizing olive oil with 4% PGPR and sodium chloride solution (8:2 ratio), followed by homogenization with 2.5% pH 9 OVM solution (3:7 ratio) to create the DE. Particle size, zeta potential, rheology, and interfacial tension analyses confirmed the stabilizing role of OVM under alkaline conditions, whereas CLSM and circular dichroism revealed the structural effects of OVM, resulting in increased α-helix and decreased β-sheet contents under acidic conditions. DE achieved an encapsulation efficiency of 93.55%, with protection rates of 82.26% in gastric fluid and 66.82% in intestinal fluid. In a dextran sulfate sodium-induced ulcerative colitis mouse model, OVM-encapsulated C. crustorum MN047 demonstrated enhanced effects in inflammation alleviation, intestinal barrier integrity, and gut microbiota regulation. This study underscores the potential of OVM-based DE systems for probiotic oral delivery and introduces an effective encapsulation approach for gastrointestinal applications.
[Display omitted]
•Innovative use of ovomucin for W1/O/W2 emulsions encapsulating probiotics.•pH-induced structural changes enhance emulsion stability and protective effects.•Encapsulation efficiency of 93.55% and protection in gastrointestinal conditions.•Ovomucin and encapsulated probiotics alleviate DSS-induced colitis in mice.•Ovomucin-based emulsions offer potential for functional foods enhancing gut health. |
---|---|
ISSN: | 0268-005X |
DOI: | 10.1016/j.foodhyd.2025.111060 |